Organization · Accelerator
CEBINA - Central European Biotech Incubator and Accelerator
CEBINA is a biotech incubator and accelerator located in Vienna, focusing on supporting early-stage life sciences ventures in the Central and Eastern European region.
Overview
What CEBINA - Central European Biotech Incubator and Accelerator does
What CEBINA - Central European Biotech Incubator and Accelerator is
CEBINA is a biotech incubator and accelerator located in Vienna, focusing on supporting early-stage life sciences ventures in the Central and Eastern European region.
How it participates in the startup ecosystem
The current public profile supports program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Program host
- Last reviewed
- April 11, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find CEBINA - Central European Biotech Incubator and Accelerator elsewhere
Open the official website or a supported primary organization account.
Capability profile
CEBINA - Central European Biotech Incubator and Accelerator as a program host
Program thesis
CEBINA is dedicated to fostering the growth of early-stage life sciences ventures, focusing on innovation and advancements in medicine and technology.
Focus narrative
CEBINA invests in early-stage life sciences companies, providing a full-service approach that includes access to a BSL2 facility, corporate support, management mentoring, and a network of private investors. Their investment strategy encompasses pre-seed, seed, and Series A funding stages, targeting projects in therapeutic fields such as cardiovascular and metabolic diseases, lung fibrosis, cancer immunotherapy, and anti-infectives.
Value and support
CEBINA offers access to a BSL2 facility, corporate support, management mentoring, and a network of private investors to early-stage life sciences companies.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- EuropeNorth America
Alumni and track record
Alumni context
Notable portfolio companies include Eveliqure Biotechnologies, developing an oral vaccine against diarrheal diseases; Calyxha Biotechnologies, innovating small molecule anti-inflammatory drugs; Algonist Biotechnologies, developing non-opioid analgesics for chronic pain; TAG Therapeutics, focusing on ASO-based technology for telomere pathologies; and MAG – Molecular Architecture Group, supporting early drug development.
Common questions
What to know about CEBINA - Central European Biotech Incubator and Accelerator
Upseed classifies CEBINA - Central European Biotech Incubator and Accelerator under the Accelerator organization type. Its current public profile includes program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 11, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.